The establishment of a virus infection is the result of the pathogen's ability to replicate in a hostile environment generated by the host's immune system.
INTRODUCTION
Cells detect infection by recognizing molecular patterns derived from pathogen's constituents (PAMPs) or cell damage (DAMPs) . During viral infection, nucleic acid is a major signal that triggers the innate immune response, inducing a type one interferon (IFN-I)-mediated antiviral state (Gebhardt et al., 2017; Mansur et al., 2014) . IFN-I binds to its cognate receptor and activates the JAK/STAT pathway, leading to expression of hundreds of interferon stimulated genes (ISGs) that make the intracellular environment hostile to viral replication in infected and proximal cells (Schoggins, 2019) . The evolutionary arms race between viruses and its hosts led to evolution of immune evasion mechanisms that are crucial for successful viral replication. Considering IFN-I's importance in viral infection control, many immunomodulatory proteins target this signaling pathway (García-Sastre, 2017) .
Several flaviviruses, such as dengue virus (DV), Zika virus (ZIKV) and yellow fever virus (YFV), have emerged and re-emerged over recent years and are the leading cause of human arbovirus infection (Barrett, 2018; Pierson and Diamond, 2018) . DV alone infects nearly 400 million people every year (Bhatt et al., 2013) with extensive health and economic burden (Shepard et al., 2016) . One possibility for effective flavivirus emergence is their ability to counteract the human immune system.
The compact flavivirus genome encodes seven non-structural proteins that are responsible for viral replication and immune evasion. Six of these proteins are not secreted implying that intracellular pathways are central targets for evasion (Chen et al., 2017; Grant et al., 2016; Laurent-Rolle et al., 2014; Miorin et al., 2017; Ngono and Shresta, 2018) . For instance, DV nonstructural protein 5 (NS5), which is the viral RNA-dependent-RNA-polymerase (RdRp) and a methyltransferase, mediates STAT2 degradation by facilitating its interaction with UBR4, leading to its ubiquitination and subsequent proteasomal targeting (Morrison et al., 2013) . This evasion pathway is functional in humans but not mice due differences in the amino acid sequence of mouse STAT2 (Ashour et al., 2010) .
ISG15 is an intracellular and secreted ubiquitin-like protein that has three described functions. Extracellular ISG15 acts as a cytokine, leading to the expression of IFNγ and IL-10 in diverse immune cells (Dos Santos and Mansur, 2017; Dos Santos et al., 2018; Swaim et al., 2017) . It has been suggested that humans lacking ISG15 have severe mycobacterial disease due to deficiency in IFNγ production by NK cells (Bogunovic et al., 2012) .
Moreover, ISG15 mRNA is highly expressed in active tuberculosis and strongly correlates with disease severity (Delgobo et al.; Dos Santos et al., 2018) .
ISG15 is conjugated to other proteins through a three-step ubiquitination-like process (Skaug and Chen, 2010) in which the main ligase for ISGylation is the HECT domain and RCC1-like domain-containing protein 5 (HERC5) (Dastur et al., 2006; Wong et al., 2006) . ISGylated proteins are affected in several different ways, such as increased or reduced stability and activity. ISG15 can also be conjugated to viral proteins, impacting their function, and therefore belong in the plethora of ISGs with a direct antiviral function (Perng and Lenschow, 2018; Schoggins, 2019) .
The third and more recently described role of ISG15 is its IFN-I modulatory function. Non-conjugated ISG15 binds and stabilizes the ISG USP18, a protease that negatively regulates IFN-I signaling and also serve as a deISGylating protein (Arimoto et al., 2017; Malakhova et al., 2002) . Indeed, individuals lacking ISG15 are prone to severe interferonopathies due to decreased USP18 function and increased IFN-I signaling. Interestingly, ISG15-deficient patients do not have enhanced susceptibility to virus suggesting ISG15 is not necessary to control ubiquitous viral infections in vivo (Zhang et al., 2015) . Despite cells lacking ISG15 having less USP18 and sustained IFN-I signaling (Speer et al., 2016; Zhang et al., 2015) , ISG15 itself blocks Influenza and HSV-1 replication (Lenschow et al., 2007) . Although this evidence places ISG15 as an important molecule inhibiting IFN-I-mediated actions, it also suggests that ISG15 mediates host cell intrinsic mechanisms triggered by viruses. However, how ISG15 bridges these apparently two paradoxical phenomena is unclear.
Here, we observed that, unlike several other ISGs, ISG15 is highly expressed in infected cells containing the DV genome. ISG15 restricts flavivirus replication primarily in the infected cell by stabilizing USP18, which in turn competes with viral NS5 for binding to STAT2. Our results suggest that flaviviruses exploit an ISG15-mediated IFN-I regulatory mechanism to evade innate immunity and enable replication.
RESULTS

ISG15 is expressed in DV-infected cells
The cell is a fundamental unit for viral infection control and developments in single-cell sequencing technology have enabled examination of hostpathogen interactions in great detail. Recently, Zanini and colleagues generated single-cell RNA sequencing of two independent data sets of DVinfected human cells (PBMCs and the HuH7 hepatoma cell line) (Zanini et al., 2018a (Zanini et al., , 2018b . We re-analyzed available single-cell transcriptomic data dividing cells into three categories: uninfected, infected and bystander. Here we define bystander as cells that have been exposed to the virus or were derived from an infected patient but did not have the viral RNA detected. We used t-Distributed Stochastic Neighbor Embedding (tSNE) analysis to visualize cell-to-cell relationships in space of reduced dimensionality. As reported previously (Zanini et al., 2018a (Zanini et al., , 2018b , global cellular mRNA expression profiling was not sufficient to separate infected or bystander from uninfected cells, suggesting a high variability of gene expression in these samples ( Figure 1A and S1A). As IFN-I are key elements in controlling infection, we filtered the results of the differential gene expression analysis using the gene ontology (GO) term for "type one interferon". The Venn diagram in figure 1B shows that from the 394 differentially expressed (DE) genes in peripheral blood mononuclear cells (PBMCs) of patients infected with DV or healthy donors, 35 were ISGs (IFN-I GO). ISG15, UBE2L6, HERC5 and USP18, members of the ISGylation pathway, were differentially expressed during DV infection ( Figure 1C in bold). Interestingly, HERC5 was the only member of the ISGylation pathway with a higher expression level in bystander cells ( Figure 1C and D). In the data set derived from the HuH7 cell line, ISG15 was the only canonical antiviral protein expressed in DV genomecontaining cells (Figure S1C and D) . This is in agreement with previous reports that the HuH7 cell line does not respond to IFN-I properly (Keskinen et al., 1999) and could explain the high number of infected cells ( Figure S1A ) in comparison with the number of infected PMBCs ( Figure 1A ). In PBMCs, NK, NKT and monocytes were the infected cells with higher ISG15 expression and B cells and monocytes being proportionately the most infected cells ( Figure   1E ). These results show that ISG15 and other components of the ISGylation pathway are enriched in DV-infected cells.
ISG15 restricts DV and ZIKV replication
The enrichment of ISG15-related genes at a single-cell level led us to investigate how ISG15 might impact flavivirus replication in a human cell. We used an A549 cell line lacking ISG15, previously generated using CRISPR/Cas9 in our lab (Dos Santos et al., 2018) . A549 cells were chosen due to their ability to support flavivirus replication and also to produce and respond to IFN-I (Gullberg et al., 2018; Wang et al., 2018; Whelan et al., 2019; Zhang et al., 2018) .
ISG15-deficient cells were more susceptible to DV infection as shown by an increased plaque size (Figure 2A and B) and number of infected cells per plaque ( Figure 2C ). In addition, we determined the kinetics of DV replication and dissemination by using a low multiplicity of infection (MOI), to allow for viral spread through secondary infection events. Percentages of infected cells over time ( Figure 2D ), relative DV Pre-Membrane RNA quantification in the supernatant ( Figure 2E ) and infectious particle formation ( Figure 2F ) were also increased in the absence of ISG15. DV infection at 4 o C for 2 hours followed by relative intracellular DV genome quantification indicated no differences in viral RNA between WT and knockout cells up to 48 hours postinfection ( Figure 2G ), suggesting that ISG15 plays a role in the DV life cycle at a stage following viral entry. Importantly, reconstitution of ISG15 expression in knockout cells led to phenotypic reversion ( Figure 2H and I), confirming that the effects observed in our experiments were indeed caused by the lack of ISG15.
Finally, lack of ISG15 expression led to an increase in plaque size in cells infected with a phylogenetically related virus, such as ZIKV ( Figure 2J and K) but not with HSV-1 ( Figure S2A and B) or VSV ( Figure S2C and D). These results are in line with Speer and colleagues' data where cells isolated from humans deficient for ISG15 do not have enhanced susceptibility to HSV-1 or VSV (Speer et al., 2016) . Altogether these results suggest a specific role for ISG15 in the regulation of flavivirus replication and dissemination.
Extracellular ISG15 and ISGylation deficiency do not affect DV spread
One of the first properties attributed to ISG15 was that it could be secreted and act as cytokine (D'Cunha et al., 1996; Dos Santos and Mansur, 2017; Recht et al., 1991) . Recently, exogenous free ISG15 has been shown to affect ZIKV replication in corneal cells (Singh et al., 2019) . To explore whether extracellular ISG15 plays a role in controlling flavivirus replication in A549 cells, we pre-treated ISG15-deficient cells with 2 µg/ml of recombinant human ISG15 (rISG15) for 12 hours before DV infection. Pre-treatment with exogenous rISG15 had only a marginal impact on the cell's ability to control infection, indicating that the lack of extracellular free-ISG15 is not the main factor responsible for the phenotype observed in ISG15-deficient cells ( Figure   S3A and B).
ISG15 is an IFN-I-inducible ubiquitin-like molecule and can be conjugated to target proteins by HERC5, an ISG15 ligase also induced by IFN (Wong et al., 2006; Zhao et al., 2005) . Of note, ISGylation of host or viral proteins was reported to inhibit replication of several viruses such as influenza (IAV) (Zhao et al., 2010) , human cytomegalovirus (HCMV) (Kim et al., 2016) and human respiratory syncytial virus (RSV) (González-Sanz et al., 2016) . Moreover, DV proteins were also shown to be ISGylated (Hishiki et al., 2014) . To determine whether ISGylation could be involved in DV restriction, we generated HERC5deficient A549 cells using CRISPR/Cas9 ( Figure S4A ) and accordingly, A549 HERC5 null cells were not able to perform ISGylation after IFNα treatment ( Figure 3A) . In contrast to ISG15 null cells, we did not observe differences between WT and HERC5-deficient cells when we evaluated both plaque area ( Figure 3B ) and number of infected cells per plaque following infection with DV ( Figure 3C ). These results suggest that ISGylation is not sufficient to inhibit DV replication.
ISG15 is necessary for autocrine IFNAR1-mediated control of DV replication
ISG15 and its binding partner USP18 are crucial for IFN-I pathway downregulation, which is pivotal for infection control and immune-regulation in humans (François-Newton et al., 2011; Speer et al., 2016; Zhang et al., 2015) . The A549 ISG15-KO cell line exhibited a lower expression of USP18 and sustained ISG expression, as exemplified by IFIT3, after IFN-I stimulation ( Figure S5 ), reproducing the phenotype observed in cells isolated from humans lacking ISG15 (Speer et al., 2016) .
While our single-cell RNA-seq analysis showed that both ISG15 and USP18 are upregulated in PMBCs containing DV RNA, there was an asynchrony of ISGs being expressed in infected versus bystander cells, with a greater spectrum present in the latter ( Figure 1C ). This is expected as flavivirus' control of IFN-I signaling occurs mainly via its intracellular non-structural proteins (Dalrymple et al., 2015; Muñoz-Jordán et al., 2005) and few ISGs can be directly induced by IRF3 (Daly and Reich, 1993, 1995; Weaver et al., 1998) .
Of interest, STAT2 mRNA is expressed at higher levels in DV RNA-containing cells when compared to bystanders and uninfected cells ( Figure 1C ). Hence, we hypothesized that ISG15 interference with DV replication is associated with autocrine IFN-I signaling in infected cells. Confirming the results from PMBCs and HuH7 cells, ISG15 mRNA was induced in A549 cells during DV infection ( Figure 4A ). As expected, this expression was abolished in knockout cells. Therefore, we measured the activation of the IFN-I pathway in WT and ISG15-KO cells infected with DV. Despite ISG15-knockout cells having full machinery to control viral infection as well as hyper-responsiveness to exogenous IFNα ( Figure S5 , Figure 4E and F) (Speer et al., 2016; Zhang et al., 2015) , they did not respond properly to DV infection. Infected ISG15deficient cells had less STAT1 phosphorylation and IFIT1 expression when compared to WT cells and as expected had no detectable USP18 ( Figure 4B ).
Infected knockout cells, despite inducing IFNβ mRNA at higher levels than the WT, had less IFIT1 mRNA (Figures 4C and D) indicating that DV infection impairs the response at both mRNA and protein levels downstream of IFN-I induction.
Taken together, our results suggest that ISG15 inhibits DV infection by regulating early events of the IFN-I receptor activation. To test this, we constructed an ISG15/IFNAR1 double knockout cell line based on the ISG15-KO background ( Figure S4B ). Cells were infected with DV and plaque area and number of infected cells per plaque was quantified. In parallel, we performed this experiment in IFNAR1 knockout cells, previously generated by our group (Antunes et al., 2019; Guimarães et al., 2019) . The same phenotype was observed in all three cell lines, with no additive or synergistic effects in the double knockout (Figures 4G and H) , which places intracellular ISG15 downstream of IFNAR1 signaling in the control of DV infection.
ISG15 counteracts DV IFN-I evasion
Flaviviruses are known to counteract IFN-I signaling by inducing the degradation of STAT2, a key protein in the interferon signal transduction pathway (Ashour et al., 2009; Grant et al., 2016; Morrison et al., 2013) . As our previous results suggest that ISG15's role during DV infection is downstream of IFNAR engagement (Figure 4 ), we evaluated DV-mediated STAT2 degradation in the absence of ISG15. In agreement with others (Jones et al., 2005) , STAT2 degradation in the A549 cell line occurs rapidly after infection.
Despite showing sustained activation of IFN-I signaling ( Figure S5 ), ISG15-KO cells showed pronounced STAT2 degradation when infected with DV ( Figure 5A and E-upper panel). As infected IFN-secreting cells are able to induce an antiviral state in neighboring-bystander cells by inducing the expression of ISGs (Rand et al., 2012) , we then evaluated in which cell population, infected and/or bystander, ISG15 impacted DV infection. DV plaques were co-stained for flavivirus E protein and IFIT3 and confocal microscopy was performed. Both infected and bystander cells were able to respond to infection, producing IFIT3 ( Figure 5D , top panel). However, IFIT3 expression in the plaque context was largely impaired and restricted to infected cells in the absence of ISG15 (Figures 5B, C and D) . This data suggests that restriction of DV replication and dissemination is achieved by both autocrine and paracrine IFN-I response amplification and is dependent on ISG15 expression. To further investigate this, we sorted DV envelope protein positive and negative cells ( Figure S6A 
USP18 expression overcomes ISG15 deficiency
STAT2 degradation during flavivirus infection is largely dependent on NS5, the virus RdRp and methyltransferase. NS5 was shown to bind to the Nterminus of human STAT2 (Ashour et al., 2010; Grant et al., 2016) .
Interestingly, USP18 interacts with STAT2 via its coiled-coil and DNA binding domains. This causes negative regulation of IFNAR signaling by displacing JAK1 from chain 2 of the receptor (Arimoto et al., 2017) . As shown here (Figures, 4B, 5E and S5) and elsewhere (Speer et al., 2016; Zhang et al., 2015) , the absence of ISG15 results in USP18's destabilization. We therefore assessed whether NS5 is also present in the STAT2/USP18 complex. In HEK293 cells lacking ISG15 ( Figure S4C , D and E) and primed with IFNα for 18 hours, both endogenous STAT2 and overexpressed USP18, immunoprecipitated with ZIKV's NS5 ( Figure 6A , lane 2). This interaction was enhanced when a protease-deficient high-expressing USP18 mutant (C64A) was used ( Figure 6A , lane 3). We then hypothesized that the interaction of USP18 with STAT2 competes with NS5 binding, which in turn could result in a lower efficiency of virus evasion mechanism. To test this, we performed an endogenous STAT2 pull-down in ISG15-deficient HEK293 cells transfected with NS5, USP18 or a combination of both, followed by treatment with IFNα overnight. In the absence of NS5, USP18 interaction with STAT2 was markedly enhanced ( Figure 6B , lanes 2 and 3), suggesting that both proteins indeed compete for the same region of the protein.
Thus, we evaluated whether the presence of USP18 could restore STAT2 expression in ISG15 knockout cells during DV infection. Overexpression of USP18 led to an increase of STAT2 levels similar to ones seen in wild type cells ( Figure 6C ). Importantly, USP18 reconstitution in ISG15-deficient cells was also able to reduce virus replication ( Figure 6D ), suggesting that reestablishment of the IFN-I signaling was sufficient to recover the WT phenotype in ISG15 knockout cells.
Together, the results presented here reveal that human ISG15 restricts DV and ZIKV replication via its ability to stabilize USP18 and regulate the type 1 IFN signaling pathway.
DISCUSSION
A successful infection is dependent on the virus replication machinery and its ability to evade host immunity. One of the first lines of defense a virus has to overcome is a plethora of antiviral genes induced by IFN-I (Schneider et al., 2014) .
ISG15 is induced early during infection (Loeb and Haas, 1992; Ramos et al., 2019) and has been shown to have a viral restriction role in several infection models. Most of those have been reported to be a consequence of ISGylation (Durfee et al., 2010; González-Sanz et al., 2016; Kim et al., 2016; Zhao et al., 2010) , even though this process was suggested to be both inefficient and unspecific (Durfee et al., 2010) . Here we show that during the IFN-I response elicited throughout DV infection, ISGylation is redundant for antiviral immunity; rather, ISG15's ability to stabilize USP18 prevents NS5-mediated STAT2 degradation, thus leading to a more effective interferon response that culminates in DV and ZIKV restriction.
Many of ISG15's functions have been shown to be immunomodulatory. For instance, ISGylation stabilizes IRF3 by occluding its ubiquitylation sites (Shi et al., 2010) , negatively regulates RIG-I (Kim et al., 2008) and activates PKR (Okumura et al., 2013) . Secreted ISG15 works as a cytokine (D'Cunha et al., 1996; Dos Santos and Mansur, 2017) , leading to the production of IFNγ and IL-10 in human cells, crucial to the control of pathogens such as Mycobacterium tuberculosis (Bogunovic et al., 2012; Dos Santos et al., 2018) .
Moreover, free intracellular ISG15 is essential for USP18 stability (Figures, 4B, 5E, S5 and Speer et al., 2016; Zhang et al., 2015) and its absence leads to severe interferonopathy in humans (Zhang et al., 2015) . Also there are reports of ISG15 having an antiviral function independent of Ube1L during Chikungunya virus infection in mice (Werneke et al., 2011; Zhang et al., 2015) , where free ISG15 contributes to infection control by blunting potentially pathologic levels of cytokine effectors. Considering this range of functions, it is expected that different pathogens might interact with this pathway in different ways, according to its co-evolutionary history.
Of note, NK, NKT and monocytes were the PBMC populations with higher upregulation of ISG15 mRNA in single-cell gene expression studies. These have been shown to be the major producers and/or targets of free extracellular ISG15 in other contexts (Bogunovic et al., 2012; D'Cunha et al., 1996; Dos Santos et al., 2018; Swaim et al., 2017) . Therefore, although pretreatment with rISG15 had only a minor impact on DV spread in the epithelial cell line used in our study. However, the influence of extracellular ISG15 in vivo should be further explored in the future.
Interestingly, humans lacking ISG15 do not have increased susceptibility to common viral infections, such as influenza and HSV-1. The explanation for that, as suggested elsewhere, might lie on the sustained IFN-I response of their cells creating a hostile environment for virus growth (Speer et al., 2016; Zhang et al., 2015) . Our results, on the other hand, reveal that ISG15 can restrict DV and ZIKV replication by stabilizing USP18 and therefore competing for a niche exploited by these viruses. We also demonstrate that USP18, STAT2 and NS5 co-immunoprecipitate, suggesting a very narrow window of opportunity that NS5 has to degrade STAT2. As USP18/ ISG15 interaction seems to result in the down-regulation of IFN-I signaling in humans but not mice (Speer et al., 2016) , it is tempting to speculate that NS5 interaction with STAT2, a major flavivirus immune evasion mechanism and also restricted to humans (Ashour et al., 2010) , was shaped by the USP18/ISG15 interaction.
Our results suggest an unexpected mechanism by which ISG15 can exert an antiviral function distinct from the debilitating effects of its conjugation to viral proteins. The key role of IFN-I in viral infections might lead to the perception of ISGs having a necessarily direct antiviral function, a paradigm that is recently being reassessed, with a range of ISGs being implicated in infectionindependent functions (Dabo et al., 2017; Vuillier et al., 2019) . Here we provide mechanistic insight of the arms race between ISG15, USP18 and NS5 that suggests that protein/protein dynamics adjacent to IFNAR are a key determinant for the outcome of flavivirus infection. 
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METHODS
Single-cell RNA sequencing analysis
Processed, publicly available single-cell RNA-seq data are available through the GEO accession numbers GSE116672 and GSE110496. We downloaded processed single-cell data and metadata from the supplementary information from the respective publications (Zanini et al., 2018a (Zanini et al., , 2018b .
Then, we used CellRouter to analyze these datasets. To perform the tSNE analysis using single-cell data generated by Zanini 2018 (Zanini et al., 2018b , we set the parameters num.pcs=10, seed=1 and max_iter=1000 in the computeTSNE function. Next, we identified genes preferentially expressed in Uninfected, Bystander and Infected cells using a cutoff for the log2 fold change of 0.25. We used a customized script to obtain all genes containing the keywords "type I interferon" in the Gene Ontology Biological Processes.
Next, we took the overlap of type I interferon genes with the genes preferentially in each condition reported above. The remaining analyses were focused on these genes.
To perform the tSNE analysis using the single-cell data generated by Zanini 2018 (Zanini et al., 2018a) , we set the parameters num.pcs=20, seed=1 and max_iter=1000 in the computeTSNE function. We used a strategy similar to the one described above to identify genes differentially expressed in each condition but used a cutoff of 0.15 for this dataset. The parameter num.pcs was determined using the elbow approach, as described in the CellRouter tutorial at https://github.com/edroaldo/cellrouter.
CRISPR/Cas9-mediated gene editing
A549 WT and ISG15 KO cells were co-transfected with two Herc5 or Ifnar1targeting gRNA CRISPR/Cas9-GFP plasmids, respectively. HEK293 WT cells were transfected with three Isg15-targeting gRNA CRISPR/Cas9-GFP plasmids ( Table S1 .
Western blot
Human antibodies used for immunoblot were as follows: mouse mAb to β actin (Abcam, ab6276, dilution 1:4000), rabbit mAb to IFIT1 (Abcam, Membrane was washed three times with TBST and then incubated with the appropriate secondary HRP-linked antibody for 1 h at room temperature.
Membranes were washed and covered with ECL developing solution (Pierce TM ECL WB substrate, Thermo Fisher Scientific).
Plasmids and transfections
Herc5 and Ifnar1 sgRNA/Cas9/GFP plasmids were provided by Horizon (Cambridge, UK). sgRNA sequences are described in Supplementary Table   1 . Expression plasmid for ISG15 was described elsewhere (Dos Santos et al., 2018) . Pmax TM GFP expression vector was acquired from Lonza (cat numb #D-00061). Expression plasmid for ZIKV NS5 was generated by amplifying the NS5 coding sequence (amino acids 2521-3423 in the polyprotein) from a previously described plasmid-based ZIKV reverse genetic system (Mutso et al., 2017) buffer. Immunoprecipitates were subjected to SDS-PAGE and western blotting, as described above.
FLAG-tagged proteins were immunoprecipitated with anti-FLAG M2-agarose (Sigma), following the manufacturer's instructions.
All assays were performed three times and representative blots are presented. Bogunovic, D., Byun, M., Durfee, L.A., Abhyankar, A., Sanal, O., Mansouri, D., Salem, S., Radovanovic, I., Grant, A.V., Adimi, P., et al. (2012) . Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science 337, 1684-1688.
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